Target intelligence / Profile preview

FYN binding protein 1 (FYB1)

Target
FYB1
Molecular classification
Adapter protein (scaffold/adaptor molecule), Signal transduction molecule, Other (not a receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

FYN binding protein 1 (FYB1) is a multifunctional adapter protein expressed predominantly in immune cells such as T cells, NK cells, monocytes, and mast cells. It plays a central role in T-cell receptor signaling, linking FYN kinase activity with cytoskeletal reorganization, immune cell adhesion, cytokine production, and platelet activation. FYB1 features multiple protein interaction domains and functions as a scaffold in complexes regulating actin dynamics, integrin-mediated signaling, and immune cell activation. Dysregulation of FYB1 is implicated in immune deficiencies and platelet disorders, and its signaling may be altered by pathogenic bacteria or genetic mutations

Other names
FYB1FYBADAP (Adhesion and degranulation-promoting adapter protein)SLAP-130 (SLP-76-associated phosphoprotein)FYN-bindingFYB-120/130p120/130 (isoforms)B630013F22RIKPRO0823RGD1563421THC3
02

Mechanism of action

Drugs modulating FYB1 downstream effects would: - Alter T-cell activation through FYN/ADAP/SLP-76 axis - Regulate immune cell adhesion and migration by affecting integrin signaling - Influence cytokine production (e.g., IL-2 expression) - Modulate platelet activation and function

03

Biological functions

Signal transduction in T cells (FYN kinase, LCP2 signaling cascades)Cell adhesion (especially in T cells and mast cells)Platelet activationCytokine production (e.g. interleukin-2 regulation)Actin cytoskeleton remodelingImmune cell activation and migration
04

Disease associations

Immune system disorders (e.g., altered T cell activation)Thrombocytopenia (both congenital and autosomal recessive forms)Platelet disorders (small-platelet thrombocytopenia)Potential role in infection, due to involvement in macrophage signaling affected by bacterial virulence factorsOther (immune-related diseases)
05

Safety considerations

Risk of immunosuppression if targeted too aggressivelyPotential interference with normal platelet activity, leading to bleeding or clotting disorders (thrombocytopenia)Off-target effects due to its multifunctionality in immune cells
06

Biomarkers

FYB1 expression (for T-cell activation states, immune disorders involving T-cell signaling, or platelet activation abnormalities)

Beyond the preview

Go deeper on FYN binding protein 1 (FYB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FYN binding protein 1 (FYB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call